Scarica l'app Stockscreener
3.24
2.99%
-0.10
Dopo l'orario di chiusura:
3.39
0.15
+4.63%
Precedente Chiudi:
$3.34
Aprire:
$3.35
Volume 24 ore:
44,502
Relative Volume:
0.72
Capitalizzazione di mercato:
$32.85M
Reddito:
-
Utile/perdita netta:
$-11.61M
Rapporto P/E:
-2.5027
EPS:
-1.2946
Flusso di cassa netto:
$-11.82M
1 W Prestazione:
-1.82%
1M Prestazione:
-23.22%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.24
$3.55
Intervallo di 1 settimana:
$3.06
$3.55
Portata 52W:
$2.88
$4.965
Grace Therapeutics Inc Stock (GRCE) Company Profile
Nome
Grace Therapeutics Inc
Settore
Industria
Telefono
609-322-1602
Indirizzo
103 CARNEGIE CENTER, PRINCETON
Confronta GRCE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.24 | 32.85M | 0 | -11.61M | -11.82M | -1.2946 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 120.86B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 77.62B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.62B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.20B | 3.30B | -501.07M | 1.03B | -2.1146 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-09-01 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-06 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | Iniziato | B. Riley FBR | Buy |
| 2019-07-18 | Iniziato | Oppenheimer | Outperform |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Grace Therapeutics Inc Borsa (GRCE) Ultime notizie
MaRS appoints Grace Lee Reynolds as CEO and welcomes new leaders to the board - Yahoo Finance
Corcept Therapeutics stock soars to all-time high of $70.78 - MSN
University President Mourns Student Who Died in Midair Collision - Yahoo Finance
The Orlando Credit Union Charitable Foundation Opens Applications for 2025 Grace Chewning Scholarship Fund - Yahoo Finance
Viracta Therapeutics strikes deal to avoid default - MSN
3 US Penny Stocks With Market Cap Under $70M - Simply Wall St
Nav Welcomes Grace Liu as Chief Financial Officer - Yahoo Finance
HEAVY.AI Announces Availability of Analytics Platform Accelerated by NVIDIA Grace Hopper Superchip - Yahoo Finance
Woolworths, Coles' horror $4.1 billion fall from grace: 'Very significant' - Yahoo Finance Australia
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement - Yahoo Finance
EPF introduces faster access, monthly activation for Simpanan Shariah - The Malaysian Reserve
Traumatic Brain Injury Pipeline Insights 2024: Therapies, Clinical Trials, and Treatment Outlook | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Laboratories, Integra LifeSciences Corp - The Globe and Mail
Traumatic Brain Injury Pipeline Insights 2024: Therapies, - openPR
Nvidia debuts GB10 superchip, AI systems for humanoid robots, self-driving trucks at CES 2025 - Yahoo Finance
Grace Therapeutics to Participate in Upcoming Investor Events January 2025 - The Manila Times
Grace Therapeutics to Present Novel aSAH Treatment at Major January Healthcare Events - StockTitan
NVIDIA Puts Grace Blackwell on Every Desk and at Every AI Developer’s Fingertips - Yahoo Finance
Delta's 'saving grace' for Q4 will be lower fuel prices: Analyst - Yahoo Finance
China's No 2 chip foundry Hua Hong names former Intel veteran as new president - Yahoo Finance
Corcept Therapeutics Submits FDA Application for Breakthrough Cushing's Syndrome Treatment Relacorilant - StockTitan
Nvidia unveils GB200 NVL4 with two Grace CPUs and four Blackwell GPUs for modern data center workloads - Yahoo Finance
Steve Kimock: All You Need Is Love - MetroWest Daily News
A secretary turned $180 into $7.2 million by holding her employer's stock for 75 years - Yahoo Finance
Grace Therapeutics And 2 Other US Penny Stocks Worth Watching - Simply Wall St
Zepbound, Mounjaro shortages are resolved, FDA confirms - BioPharma Dive
A new era of targeted therapy with antibody–drug conjugates - News-Medical.Net
CORTCorcept Therapeutics Inc. Latest Stock News & Market Updates - StockTitan
CORT's Dazucorilant Fails to Meet Goal in Neurologic Disorder Study - MSN
Stretch Your Dollar: Users save hundreds by automating FSA claims for purchases - Yahoo Finance
GRCE: aSAH KOL Summary - Zacks Small Cap Research
Crown Labs announces merger with Revance Therapeutics | News - Johnson City Press
SUBARU ANNOUNCES 2025 SUBARU WINTERFEST LOCATIONS AND MUSIC LINEUP WITH HEADLINER GRACE POTTER - Yahoo Finance
Acasti Pharma stock soars to 52-week high of $3.61 By Investing.com - Investing.com Canada
A.C. Grace's UNIQUE E Reaffirmed as ConsumerLab.com's Top Pick for Natural Vitamin E - Yahoo Finance
Acasti Pharma stock soars to 52-week high of $3.61 - Investing.com India
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - The Manila Times
Grace Therapeutics to Showcase Novel aSAH Treatment at Major ASHP Clinical Meeting Ahead of Phase 3 Data - StockTitan
Acasti Pharma to Report Third Quarter 2023 Financial Results on Tuesday, February 14, 2023 - Quantisnow
Iteos Therapeutics Inc (ITOS-Q) QuotePress Release - The Globe and Mail
Arm Holdings plc (ARM) Showcases Power Efficiency with NVIDIA’s 72-Core Grace CPU - Yahoo Finance
Grace Therapeutics Reports Steady Progress and Financials - TipRanks
GRCE (Grace Therapeutics) Total Inventories : $0.00 Mil (As of Sep. 2024) - GuruFocus.com
GRCE: FY:25 Second Quarter Results - MSN
WEKA Unveils Industry's First AI Storage Cluster Built On NVIDIA Grace CPU Superchips - Yahoo Finance
Twist Bioscience rises 13% on FQ4 earnings beats, 2025 revenue outlook - MSN
Altair Solutions Now Supported on NVIDIA Grace Hopper and Grace CPU Superchip Architectures - Yahoo Finance
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOn November 13, 2024, Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company focusing on innovative therapies for rare cardiopulmonary dise - Defense World
Horizon Space Acquisition I Corp. Approved for Listing on Nasdaq Capital Market - Defense World
Seres Therapeutics Receives Notification from Nasdaq Regarding Bid Price Requirement - Defense World
Chain Bridge I Faces Delisting from Nasdaq Due to Non-Compliance with Listing Rule - Defense World
BioRestorative Therapies Provides Business Update and Financial Results for Q3 2024 - Defense World
Grace Therapeutics Inc Azioni (GRCE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):